 |
Matter handles Abpro, a biotechnology company that develops antibody therapies to treat cancers, as it merges with Atlantic Coastal Acquisition Corp. in a SPAC deal worth $725M.
Ian Chan, CEO & co-founder of Abpro, said the SPAC represents a milestone for the Woburn, MA-based company.
Proceeds from the transaction will help “accelerate the advancement of our pipeline toward clinical trials and provide the foundation for ongoing development of novel immunotherapies to help patients,” said Chan.
Abpro is currently in the developmental stage with its HER2+ treatments for breast, gastric and colorectal cancers.
It also has a partnership with South Korea’s Celltrion pharmaceutical company. Celltrion has made an equity investment in Abpro.
The SPAC deal is expected to close in Q2 2024.
Matter’s Deanna Meservey handles Abpro.
Kekst CNC is providing media support for the Japanese owner of the 7-Eleven convenience store chain, which has rejected a $39B takeover offer by the Canadian owner of its rival Circle K network. (Updated on 12/6)
Kekst CNC represents Agriculture & Natural Solutions Acquisition Corp. as it acquires Australian Food & Agriculture Co. in a SPAC deal valued at $510M.
There’s no shortcut to relationship building in the world of financial services PR.
Why press releases and media relations are table stakes.
Richard Dukas, founder and CEO of Dukas Linden PR, a financial services PR specialist headquartered in New York City, talked with O’Dwyer’s about life running an independent agency, tackling election-year obstacles, employing AI, and the post-COVID work environment.
Have a comment? Send it to
No comments have been submitted for this story yet.